Skip to main content

Table 1 Patient characteristics

From: Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

Characteristics

No. of patients (%)

Age

 Median

72

 Range

48–88

Sex

 Male

133 (92.4)

 Female

11 (7.6)

Former or current smokers

 Yes

141 (97.9)

 No

3 (2.1)

Pathological stage

 IA

48 (33.3)

 IB

40 (27.8)

 IIA

21 (14.6)

 IIB

11 (7.6)

 IIIA

23 (16.0)

 IIIB

1 (0.70)

Recurrence

 Yes

62 (43.1)

 No

82 (56.9)

Lymphatic permeation

 Yes

72 (50.0)

 No

72 (50.0)

Venous Invasion

 Yes

72 (50.0)

 No

72 (50.0)

Post-operative adjuvant therapy

 Yes

39 (27.1)

 UFT based

17 (51.5)

 TS-1 based

8 (24.2)

 CBDCA based

5 (15.1)

 CDDP based

3 (9.1)

 No

105 (72.9)